Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19
暂无分享,去创建一个
T. Yeo | L. Rénia | L. Ng | M. Chen | Y. Leo | L. Cui | D. Lye | B. Young | O. Ng | K. Marimuthu | L. Ang | T. Mak | M. Chan | S. Vasoo | P. Lim | P. Chia | B. Ang | L. Ling | L. Lee | S. Sadarangani | C. S. Wong | Y. Chan | Stephanie Sutjipto | Pei Hua Lee | Siew‐Wai Fong | D. H. L. Ng | M. Sadasiv | Chiaw Yee Choy | Jun-Yang Tay | A. C. Ping | Ding Ying | C. Lee | Angela Chow Li Brenda Sze Peng Chen Seong Cheng Chuan Din Ping Ang Wong Lee Ying Tay Marimuthu Lee L
[1] E. Romano. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19. , 2021, Arquivos brasileiros de cardiologia.
[2] A. Zangrillo,et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study , 2020, The Lancet Rheumatology.
[3] G. Gao,et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[4] Antonio Bertoletti,et al. A Dynamic Immune Response Shapes COVID-19 Progression , 2020, Cell Host & Microbe.
[5] Q. Ye,et al. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.
[6] Q. Ye,et al. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.
[7] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[8] Haiyan Qiu,et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study , 2020, Lancet. Infectious Diseases (Print).
[9] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[10] H. Dai,et al. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 , 2020, International Journal of Infectious Diseases.
[11] Lei Liu,et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome , 2020, medRxiv.
[12] J. Low,et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. , 2020, JAMA.
[13] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[14] Zheng Zhao,et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures , 2020, The Lancet.
[15] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[16] Y. Leo,et al. De-isolating Coronavirus Disease 2019 Suspected Cases: A Continuing Challenge , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[18] L. Chen,et al. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[19] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[20] Cindy Leung,et al. Association of a Workplace Sales Ban on Sugar-Sweetened Beverages With Employee Consumption of Sugar-Sweetened Beverages and Health. , 2020, JAMA internal medicine.
[21] Y. Ye,et al. The Regulation of Seventeen Inflammatory Mediators are Associated with Patient Outcomes in Severe Fever with Thrombocytopenia Syndrome , 2018, Scientific Reports.
[22] C. Dinarello. Overview of the IL‐1 family in innate inflammation and acquired immunity , 2018, Immunological reviews.
[23] P. Fallahi,et al. Interferon-γ-induced protein 10 in Dengue Virus infection. , 2016, Clinica Terapeutica.
[24] Sheena McCormack,et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.
[25] Yanli Wang,et al. Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus , 2012, PloS one.
[26] Y. Carmi,et al. IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation , 2011, The Journal of Immunology.
[27] R. Flavell,et al. Recent advances in IL-22 biology. , 2011, International immunology.
[28] K. Sauer,et al. IL-21 Is Required to Control Chronic Viral Infection , 2009, Science.
[29] L. Rosenwasser,et al. Biologic activities of IL-1 and its role in human disease. , 1998, The Journal of allergy and clinical immunology.
[30] R. Weinstein,et al. Magnitude and prevention of nosocomial infections in the intensive care unit. , 1997, Infectious disease clinics of North America.
[31] M. Reale,et al. Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures. , 1992, Cellular immunology.
[32] Melbourne Victoria,et al. A Ministry of Health , 1917, Nature.
[33] Ong Ye,et al. THE STRAITS TIMES , 2017 .
[34] C. Gabay,et al. Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.